Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
about
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.Effects of Incretin-Based Therapies on Diabetic Microvascular Complications.The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological StudyThe effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.Intestinal Incretins and the Regulation of Bone Physiology.Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study
P2860
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@ast
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@en
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@nl
type
label
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@ast
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@en
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@nl
prefLabel
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@ast
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@en
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@nl
P2093
P2860
P921
P3181
P356
P1476
Incretin-Based Therapies for D ...... chanisms and Clinical Evidence
@en
P2093
Daiji Kawanami
Kazunori Utsunomiya
Keiichiro Matoba
P2860
P3181
P356
10.3390/IJMS17081223
P407
P5008
P577
2016-07-29T00:00:00Z